Stocktoria

CDT Equity Inc. CDT

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2022-02-03

CDT Equity Inc. statistics & valuation

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2022202320242025
Operating margin (%)
2022202320242025
Return on equity (%)
2022202320242025
Shares outstanding
64.6M 738295 461 33300 2022202320242025
Net debt ($)
2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-97740.00% -7.40% -424.60% -694.20% 2022202320242025
Free cash flow margin (%)
2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
-$0.13 -$8.92 -$61598.62 -$1177.89 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Return on assets-694.2%-424.6%-7.4%-97740.0%
Return on equity547.1%262.1%117.1%48.4%
Current ratio0.340.253.180.15

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.